Background:Diabetic patients with Non ST Elevated Myocardial Infarction (NSTEMI) are at high risk for subsequent cardiovascular events. But, early Percutaneous Coronary Intervention (PCI) in group of NSTEMI significantly prove the primary outcomes.

Background: It has been estimated that nearly one-fifth post-percutaneous coronary intervention (PCI) patients treated with clopidogrel continued to have recurrent thrombotic events, which implied the limitation of “one-size-fits all” strategy for antiplatelet therapy.

Background:Diabetic patients with Non ST Elevated Myocardial Infarction (NSTEMI) are at high risk for subsequent cardiovascular events. But, early Percutaneous Coronary Intervention (PCI) in group of NSTEMI significantly prove the primary outcomes.

BACKGROUND The best strategy for ST-segment elevation myocardial infarction (STEMI) patients with multivessel disease (MVD), who underwent primary percutaneous coronary intervention (PCI) in the acute phase, is not well established. OBJECTIVES Our goal was to conduct a meta-analysis comparing culprit vessel only percutaneous coronary intervention (culprit PCI) with multivessel percutaneous co...

Percutaneous coronary intervention (PCI) for coronary artery chronic total occlusion (CTO) is an important treatment to be used in conjunction with non-CTO PCI, coronary artery bypass grafting, and optimal medical therapy to achieve complete revascularization in patients with coronary artery disease.

The aim of this study is to determine risks factor of mortality among patient with post percutaneous coronary intervention. Estimation of post operative mortality risk factor is essential for planning prevention modalities. This is retrospective cohort study based on secondary data extracted from the National Cardiovascular Disease Database (NCVD-ACS and NCVD PCI). Both these registries were in...

1. Steinhubl SR, Berger PB, Mann JT III, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;288:2411–20. 2. Mehta SR, Yusuf S, Peters RJG, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE st...

Introduction : Significant left main coronary artery stenosis jeopardizes the entire myocardium of the left ventricle and has the worst prognosis of any form of coronary artery disease. Coronary-artery bypass grafting (CABG) has been considered as the standard therapeutic approach for such patients. There are limited data on the safety and effectiveness of percutaneous coronary intervention (PC...

Hybrid revascularization of multivessel coronary artery disease by combining bypass grafting (CABG) and chronic total occlusion (CTO) percutaneous intervention (PCI) is a relatively novel concept. CABG-CTO PCI aims to combine the durable clinical benefits left internal mammary graft (ideally minimally invasively) with durability CTO in non-left anterior descending vessels. This review assesses ...